How Blockbuster Drugs Fight Off Cheaper Competition

A lower-priced version of blockbuster Remicade hasn’t sold well, will an even cheaper drug upend the obscure pricing of the drug industry?

from WSJ.com: Markets http://ift.tt/2twdDKK
via https://ifttt.com/ IFTTT